Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.
The Conversation logo

Do you own an oximeter? If so, do you know how and when to use it? It could save your life.

COVID-19 has killed at least 60,000 people in the UK. Many who die have a sudden drop in their blood oxygen levels a day or two before their lungs fail. Unlike in many other chest diseases (asthma, for example), COVID-19 can cause a severe drop in blood oxygen level without any associated breathlessness.

Because of this, people with this “silent hypoxia” are unlikely to seek the urgent help they need, unless they regularly measure their blood oxygen level or their condition deteriorates. If they realise something is wrong, they may reach hospital just in time to receive oxygen therapy (and, if necessary, ventilation). Others are admitted too late to save – or die at home.

The blood oxygen level is one of the strongest predictors of death in COVID-19, and early oxygen improves survival. So it’s time to learn to measure yours and to know what to do if it’s low.

Read the full article on The Conversation website, co-written by Professor Trish Greenhalgh (Nuffield Department of Primary Care Health Sciences)

Oxford is a subscribing member of The ConversationFind out how you can write for The Conversation.

Similar stories

Oxford Researchers elected to Royal Society

Awards and Appointments General

Six scientists from the University of Oxford, including Professor Adrian Hill and Professor Frances Platt from the Medical Sciences Division, have joined the Royal Society as Fellows.

Student Prizes for Biomedical Sciences and Medicine 2020-2021

Awards and Appointments General

Congratulations to all our Biomedical Sciences students and Medicine students who have been awarded prizes during the 2020-2021 academic year.

Multi-partner 'OpenMind' consortium to develop technology for new generation of neurostimulation devices

General Research

Investigators at the University of Oxford, University of California San Francisco (UCSF), Brown University and the Mayo Clinic have joined forces to develop open-source technology platforms for a new generation of neurostimulation devices that not only provide stimulation to the brain but also sense, record, and stream brain activity.

Why we must expand newborn screening

General Research

Professor Laurent Servais of the Department of Paeditrics writes for the Oxford Science Blog on why it is important that we become much more efficient in the diagnosis of treatable conditions and in the treatment of these diseases.

Top place for Oxford Clinical Medical Student in prestigious national Ophthalmology Duke Elder Prize Examination

Awards and Appointments General

Sixth year Clinical Medical student, Ryan Purdy (Worcester College), placed first in the Royal College of Ophthalmology's annual Prize Examination.